Pranlukast regulates tumour growth by attenuating IL-4 production in Kimura disease.
Ohtsuka
Yoshikazu
Y
Department of Paediatrics, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan. yohtsuka@med.juntendo.ac.jp
Shimizu
Toshiaki
T
Fujii
Tohru
T
Sato
Tetsuji
T
Saito
Masahiro
M
Nagata
Satoru
S
Takahashi
Hiroshi
H
Yamashiro
Yuichiro
Y
D000293:Adolescent; D000796:Angiolymphoid Hyperplasia with Eosinophilia / Q000097:blood / Q000188:drug therapy*; D002648:Child; D002867:Chromones / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D015847:Interleukin-4 / Q000097:blood*; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D008297:Male; D016896:Treatment Outcome
D002867:Chromones; D020024:Leukotriene Antagonists; D015847:Interleukin-4; C047681:pranlukast